These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10825321)

  • 1. 14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.
    Freye E; Schmidhammer H; Latasch L
    Anesth Analg; 2000 Jun; 90(6):1359-64. PubMed ID: 10825321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects.
    Freye E; Latasch L; Portoghese PS
    Eur J Anaesthesiol; 1992 Nov; 9(6):457-62. PubMed ID: 1330549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
    Freye E; Levy JV
    Eur J Anaesthesiol; 2010 Feb; 27(2):174-80. PubMed ID: 20077594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sufentanil-related respiratory depression and antinociception in the dog. Mediation by different receptor types.
    Latasch L; Freye E
    Arzneimittelforschung; 2002; 52(12):870-6. PubMed ID: 12572526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chlordiazepoxide on opioid-induced antinociception and respiratory depression in restrained rats.
    Verborgh C; De Coster R; D'Haese J; Camu F; Meert TF
    Pharmacol Biochem Behav; 1998 Mar; 59(3):663-70. PubMed ID: 9512069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intravenous naltrindole and naltrindole 5'-isothiocyanate on sufentanil-induced respiratory depression and antinociception in rats.
    Verborgh C; Meert TF
    Pharmacol Biochem Behav; 1999 May; 63(1):175-83. PubMed ID: 10340539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats.
    Verborgh C; Meert TF
    Pain; 1999 Oct; 83(1):17-24. PubMed ID: 10506668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of S-(+)-ketamine with opiate receptors. Effects on EEG, evoked potentials and respiration in awake dogs].
    Freye E; Latasch L; Schmidhammer H; Portoghese P
    Anaesthesist; 1994 Nov; 43 Suppl 2():S52-8. PubMed ID: 7840415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine.
    Latasch L; Freye E
    Acta Anaesthesiol Belg; 1993; 44(3):93-102. PubMed ID: 8310788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats.
    Chevillard L; Mégarbane B; Risède P; Baud FJ
    Toxicol Lett; 2009 Dec; 191(2-3):327-40. PubMed ID: 19819313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception.
    Guenther U; Theuerkauf NU; Huse D; Boettcher MF; Wensing G; Putensen C; Hoeft A
    Anesthesiology; 2012 Jan; 116(1):56-64. PubMed ID: 22082683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is sufentanil a useful opioid for laryngomicroscopy?
    Steinfath M; Scholz J; Tonner PH; Kycia B; Konietzko T; Bause H; Schulte am Esch J
    Acta Anaesthesiol Scand; 1996 Sep; 40(8 Pt 1):883-8. PubMed ID: 8908222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaesthesia in medetomidine premedicated New Zealand White rabbits: a comparison between intravenous sufentanil-midazolam and isoflurane anaesthesia for orthopaedic surgery.
    Hedenqvist P; Edner A; Jensen-Waern M
    Lab Anim; 2014 Apr; 48(2):155-63. PubMed ID: 24464922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the maximum tolerated dose of intranasal sufentanil and midazolam in Chinese: a pilot study.
    Zou Y; Shao L; Tian M; Zhang Y; Liu F
    Acta Anaesthesiol Scand; 2018 Jul; 62(6):773-779. PubMed ID: 29377056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    Barrett AC; Smith ES; Picker MJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three narcotic antagonists (naltrexone, diprenorphine, and S-20682) on blood pressure, heart rate and electrical cortical activity.
    Freye E; Hartung E; Schenk GK
    Pharmacology; 1983; 26(2):110-6. PubMed ID: 6133288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
    Korak-Leiter M; Likar R; Oher M; Trampitsch E; Ziervogel G; Levy JV; Freye EC
    Intensive Care Med; 2005 Mar; 31(3):380-7. PubMed ID: 15714323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dexmedetomidine and sufentanil for conscious sedation in patients undergoing awake fibreoptic nasotracheal intubation: a prospective, randomised and controlled clinical trial.
    Shen SL; Xie YH; Wang WY; Hu SF; Zhang YL
    Clin Respir J; 2014 Jan; 8(1):100-7. PubMed ID: 23906186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.